Previous close | 1.0100 |
Open | 1.0300 |
Bid | 0.9947 x 300 |
Ask | 1.0200 x 500 |
Day's range | 0.9900 - 1.0300 |
52-week range | 0.9800 - 5.6400 |
Volume | |
Avg. volume | 740,445 |
Market cap | 90.315M |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Restructuring Plan Aims to Extend Cash Runway Amid Clinical Development Focus
Vertex (VRTX), CRSP and Allakos are in the spotlight on regulatory and pipeline updates.